Article Text

PDF
Randomised controlled trial
Cytisine is more effective than nicotine replacement for smoking cessation
  1. John A Stapleton
  1. Department of Addiction, King's College London, Institute of Psychiatry, Psychology & Neuroscience, London, UK
  1. Correspondence to : Dr John A Stapleton, Department of Addiction, King's College London, Institute of Psychiatry, Psychology & Neuroscience, 16 De Crespigny Park, London SE5 8AF, UK; john.stapleton{at}kcl.ac.uk

Statistics from Altmetric.com

Commentary on: OpenUrlCrossRefPubMed

Context

Smoking is a nicotine-based addiction affecting about a billion people worldwide.1 Inhaling the tars and carbon monoxide from burned tobacco causes the premature death of about two-thirds of those who smoke throughout their lives and is the leading cause of preventable mortality and morbidity.2 Effective pharmacological therapies have helped reduce smoking prevalence in wealthier countries, but are prohibitively expensive in poorer countries where smoking is most prevalent.3 ,4

Cytisine is a low-cost cessation treatment, which has been licensed in a few Eastern European countries since the 1960s. It is an alkaloid partial agonist of nicotinic …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.